Engineered polymerases

Patent metadata

Field	Value
Publication number	US-12139727-B2
Application number	US-202217705043-A
Country	US
Kind code	B2
Filing date	Mar 25, 2022
Priority date	Jun 18, 2021
Publication date	Nov 12, 2024
Grant date	Nov 12, 2024

Abstract

Provided herein are engineered variants of archaeal, prokaryotic, and eukaryotic polymerases that exhibit enhanced thermostability, enhanced incorporation of 3′ modified nucleotides, and improved uracil-tolerance, in polymerase-catalyzed nucleotide extension reactions relative to wild type polymerase enzymes. Also provided are uses of the engineered polymerases for forming complexed polymerases, forming binding complexes and forming ternary complexes, and uses for conducting nucleic acid sequencing reactions.

First claim

The invention claimed is:

1. A method for performing nucleic acid sequencing, comprising:
(a) contacting an engineered polymerase with (i) a nucleic acid template molecule and (ii) a nucleic acid primer,
wherein said contacting is conducted under a condition suitable for the engineered polymerase to bind to the nucleic acid template molecule and the nucleic acid primer, thereby forming a complexed polymerase, wherein the complexed polymerase comprises an engineered polymerase bound to a nucleic acid duplex,
wherein the nucleic acid duplex comprises the nucleic acid template molecule hybridized to the nucleic acid primer,
wherein the engineered polymerase comprises an amino acid sequence having at least 90% sequence identity to the amino acid sequence of SEQ ID NO:1 and has amino acid substitutions Asp141Ala and Glu143Ala;

(b) contacting the complexed polymerase with a multivalent polymer-nucleotide conjugate to form a multivalent-binding complex,
wherein the multivalent polymer-nucleotide conjugate comprises a core attached to multiple nucleotide arms,
wherein at least one of the nucleotide arms is attached to a nucleotide unit,
wherein said contacting is conducted under a condition suitable for
binding the nucleotide unit of at least one of the nucleotide arms of the multivalent polymer-nucleotide conjugate to a corresponding complementary nucleotide base of the nucleic acid template molecule, and
inhibiting polymerase-catalyzed extension of the nucleic acid duplex;

(c) detecting the multivalent-binding complex; and
(d) determining the sequence of the nucleic acid template molecule.

2. The method of claim 1 , further comprising:
(e) dissociating the multivalent-binding complex, wherein said dissociating comprises:
dissociating the engineered polymerase and its bound multivalent polymer-nucleotide conjugate from the nucleic acid duplex while retaining the nucleic acid duplex;

(f) contacting the retained nucleic acid duplex with a second engineered polymerase under a condition suitable for the second engineered polymerase to bind to the retained nucleic acid duplex, thereby forming a second complexed polymerase,
wherein the second complexed polymerase comprises a second engineered polymerase bound to the retained nucleic acid duplex,
wherein the second engineered polymerase comprises an amino acid sequence having at least 90% sequence identity to the amino acid sequence of SEQ ID NO: 1 and has amino acid substitutions Asp141Ala and Glu143Ala; and

(g) contacting the second complexed polymerase with a free nucleotide or free nucleotide derivative, thereby forming a nucleotide-binding complex,
wherein said contacting is conducted under a condition suitable for polymerase-catalyzed extension of the nucleic acid duplex.

3. The method of claim 2 , further comprising:
(h) detecting complementary nucleotides in the nucleotide-binding complex.

4. The method of claim 3 , further comprising:
(i) identifying nucleotide bases of the complementary nucleotides in the nucleotide-binding complex.

5. The method of claim 1 , wherein said contacting the complexed polymerase with the multivalent polymer-nucleotide conjugate of step (b) is conducted in the presence of a non-catalytic divalent cation that inhibits polymerase-catalyzed nucleotide incorporation, wherein the non-catalytic divalent cation comprises strontium or barium.

6. The method of claim 2 , wherein said contacting the second complexed polymerase with the free nucleotide or free nucleotide derivative of step (g) is conducted in the presence of a catalytic divalent cation that promotes polymerase-catalyzed nucleotide incorporation, wherein the catalytic divalent cation comprises magnesium or manganese.

7. The method of claim 1 , wherein the nucleic acid template molecule in step (a) comprises a clonally amplified template molecule.

8. The method of claim 1 , wherein the nucleic acid template molecule of step (a) comprises a copy of a target sequence of interest or comprises a concatemer having two or more tandem copies of a target sequence of interest.

9. The method of claim 1 , wherein the nucleic acid template molecule in step (a) comprises a single target sequence or multiple different target sequences.

10. The method of claim 1 , wherein at least one of the nucleotide arms of the multivalent polymer-nucleotide conjugate comprises:
(i) a core attachment moiety,
(ii) a spacer, and
(iii) a linker,
wherein the core of the multivalent polymer-nucleotide conjugate is attached to at least one of the nucleotide arms via the core attachment moiety, wherein the spacer is attached to the linker, and wherein the linker is attached to the nucleotide unit that is carried by the at least one of the nucleotide arms.

11. The method of claim 10 , wherein the linker comprises an aliphatic chain having 2-6 subunits or an oligo ethylene glycol chain having 2-6 subunits.

12. The method of claim 10 , wherein the plurality of nucleotide arms attached to the core of the multivalent polymer-nucleotide conjugate have the same type of nucleotide units, and wherein the nucleotide unit is selected from a group consisting of dATP, dGTP, dCTP, dTTP and dUTP.

13. The method of claim 10 , wherein the multivalent polymer-nucleotide conjugate comprises one type of nucleotide unit selected from a group consisting of dATP, dGTP, dCTP, dTTP and dUTP.

14. The method of claim 1 , wherein the multivalent polymer-nucleotide conjugate is labeled with a fluorophore.

15. The method of claim 1 , wherein the contacting in steps (a) and (b) are conducted at an isothermal temperature of 25-75° C.

16. The method of claim 1 , wherein the detecting of step (c) and identifying of step (d) are conducted at an isothermal temperature of 25-75° C.

17. The method of claim 2 , wherein the free nucleotide or free nucleotide derivative in step (g) comprises an aromatic base, a five carbon sugar, and 1-10 phosphate groups.

18. The method of claim 17 , wherein the free nucleotide or free nucleotide derivative of step (g) comprises the free nucleotide or free nucleotide derivative selected from a group consisting of dATP, dGTP, dCTP, dTTP and dUTP.

19. The method of claim 17 , wherein the free nucleotide or free nucleotide derivative in step (g) is labeled with a fluorophore.

20. The method of claim 17 , wherein the free nucleotide or free nucleotide derivative in step (g) lack a fluorophore label.

21. The method of claim 17 , wherein the free nucleotide or free nucleotide derivative in step (g) comprises a removable chain terminating moiety attached to the 3′ carbon position of the sugar group, wherein the removable chain terminating moiety comprises an alkyl group, alkenyl group, alkynyl group, allyl group, aryl group, benzyl group, azide group, azido group, O-azidomethyl group, amine group, amide group, keto group, isocyanate group, phosphate group, thio group, disulfide group, carbonate group, urea group, or silyl group, and wherein the removable chain terminating moiety is cleavable with a chemical compound to generate an extendible 3′OH moiety on the sugar group.

22. The method of claim 1 , wherein the complexed polymerase in step (a) is immobilized to a support or immobilized to a coating on the support to form an immobilized complexed polymerase.

23. The method of claim 22 , wherein the density of the complexed polymerase immobilized to the support is 10 2 -10 9 per mm 2 .

24. The method of claim 22 , wherein

Assignees

• Element Biosciences Inc

Inventors

• Ambroso Mark
• Lopez Tyler
• Klein Michael
• Saade Virginia
• Kellinger Matthew

Classifications

• C12Q1/6834

  Enzymatic or biochemical coupling of nucleic acids to a solid phase · CPC title

• C12Q1/6806

  Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence) · CPC title

• C12P19/34

  Polynucleotides, e.g. nucleic acids, oligoribonucleotides · CPC title

• C12Q1/6874

  involving nucleic acid arrays, e.g. sequencing by hybridisation · CPC title

• C12Y207/07007

  DNA-directed DNA polymerase (2.7.7.7), i.e. DNA replicase · CPC title